About: covid:PMC7360897

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7360897 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Alam, Mahboob Atar, Dan Birnbaum, Yochai French, John Hasdai, David Jneid, Hani Kaski, Juan Levine, Glenn Uretsky, Barry
is schema:about of	named entity 'Current' named entity 'IIb' named entity 'fibrinolytic therapy' named entity 'STEMI' named entity 'ST elevation' named entity 'ST depression' named entity 'ST elevation' named entity '3, 4' named entity 'STEMI' named entity 'European Society of Cardiology' named entity 'hemodynamically' named entity 'fibrin' named entity 'Fibrinolytic Therapy' named entity 'primary angioplasty' named entity 'STEMI' named entity 'streptokinase' named entity 'FTT' named entity 'Acute Myocardial Infarction' named entity 'hemodynamically' named entity 'STEMI' named entity 'contraindication' named entity '3, 4' named entity 'Infarct' named entity 'Guidelines' named entity 'letter to the editor' named entity 'USIM' named entity 'heartburn' named entity '3, 4' named entity 'class III' named entity 'fibrinolytic therapy' named entity 'Acute Myocardial Infarction' named entity 'asymptomatic' named entity 'ST depression' named entity 'reperfusion therapy' named entity 'clopidogrel' named entity 'STEMI' named entity 'fibrinolytic therapy' named entity 'fibrinolytic therapy' named entity 'streptokinase' named entity 'fibrinolytic therapy' named entity 'aspirin' named entity 'relative risk' named entity 'STEMI' named entity 'anti-platelet agents' named entity 'streptokinase' named entity 'reperfusion therapy' named entity 'ECG' named entity 'Streptokinase' named entity 'fibrinolytic therapy' named entity 'STEMI' named entity 'Second International' named entity 'reperfusion therapy' named entity 'STEMI' named entity 'ISIS' named entity 'STEMI' named entity 'STEMI' named entity 'fibrinolysis' named entity 'ST elevation' named entity 'infarct' named entity 'American Heart Association' named entity 'cough' named entity 'knowledge base' named entity 'STEMI' named entity 'STEMI' named entity 'standard of care' named entity 'subgroup analysis' named entity 'tissue plasminogen activator' named entity 'urokinase' named entity 'beta-blockers' named entity 'STEMI' named entity 'STEMI' named entity 'reperfusion therapy' named entity 'fibrinolysis' named entity 'fibrinolysis' named entity 'STEMI' named entity 'STEMI' named entity 'ECG' named entity 'ST depression' named entity 'congestive heart failure' named entity 'fibrinolytic therapy' named entity 'Fibrinolytic Therapy' named entity 'reinfarction' named entity 'FTT' named entity 'Subgroup analysis' named entity 'end point' named entity 'STEMI' named entity 'streptokinase' named entity 'randomized trial' named entity 'STEMI' named entity 'based on evidence' named entity 'STEMI'

Attributes

Values

Creator

Alam, Mahboob
Atar, Dan
Birnbaum, Yochai
French, John
Hasdai, David
Jneid, Hani
Kaski, Juan
Levine, Glenn
Uretsky, Barry

is schema:about of

named entity 'Current'
named entity 'IIb'
named entity 'fibrinolytic therapy'
named entity 'STEMI'
named entity 'ST elevation'
named entity 'ST depression'
named entity 'ST elevation'
named entity '3, 4'
named entity 'STEMI'
named entity 'European Society of Cardiology'
named entity 'hemodynamically'
named entity 'fibrin'
named entity 'Fibrinolytic Therapy'
named entity 'primary angioplasty'
named entity 'STEMI'
named entity 'streptokinase'
named entity 'FTT'
named entity 'Acute Myocardial Infarction'
named entity 'hemodynamically'
named entity 'STEMI'
named entity 'contraindication'
named entity '3, 4'
named entity 'Infarct'
named entity 'Guidelines'
named entity 'letter to the editor'
named entity 'USIM'
named entity 'heartburn'
named entity '3, 4'
named entity 'class III'
named entity 'fibrinolytic therapy'
named entity 'Acute Myocardial Infarction'
named entity 'asymptomatic'
named entity 'ST depression'
named entity 'reperfusion therapy'
named entity 'clopidogrel'
named entity 'STEMI'
named entity 'fibrinolytic therapy'
named entity 'fibrinolytic therapy'
named entity 'streptokinase'
named entity 'fibrinolytic therapy'
named entity 'aspirin'
named entity 'relative risk'
named entity 'STEMI'
named entity 'anti-platelet agents'
named entity 'streptokinase'
named entity 'reperfusion therapy'
named entity 'ECG'
named entity 'Streptokinase'
named entity 'fibrinolytic therapy'
named entity 'STEMI'
named entity 'Second International'
named entity 'reperfusion therapy'
named entity 'STEMI'
named entity 'ISIS'
named entity 'STEMI'
named entity 'STEMI'
named entity 'fibrinolysis'
named entity 'ST elevation'
named entity 'infarct'
named entity 'American Heart Association'
named entity 'cough'
named entity 'knowledge base'
named entity 'STEMI'
named entity 'STEMI'
named entity 'standard of care'
named entity 'subgroup analysis'
named entity 'tissue plasminogen activator'
named entity 'urokinase'
named entity 'beta-blockers'
named entity 'STEMI'
named entity 'STEMI'
named entity 'reperfusion therapy'
named entity 'fibrinolysis'
named entity 'fibrinolysis'
named entity 'STEMI'
named entity 'STEMI'
named entity 'ECG'
named entity 'ST depression'
named entity 'congestive heart failure'
named entity 'fibrinolytic therapy'
named entity 'Fibrinolytic Therapy'
named entity 'reinfarction'
named entity 'FTT'
named entity 'Subgroup analysis'
named entity 'end point'
named entity 'STEMI'
named entity 'streptokinase'
named entity 'randomized trial'
named entity 'STEMI'
named entity 'based on evidence'
named entity 'STEMI'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software